Key result
Individualized medical therapy for pediatric patients with recurrent syncope and asystole during tilt testing prevented recurrent syncope in 78% of patients over a median 31-month follow-up.
Why the study?
Does individualized medical therapy prevent recurrent syncope in pediatric patients with cardioinhibitory syncope?
Population
18 pediatric patients with neurally mediated syncope and an asystolic response during baseline upright tilt…
Design
Cohort
Follow-up
median 31 months
Authors
Loading...
May support pacing avoidance in pediatric cardioinhibitory syncope; hypothesis-generating and requires randomized confirmation.
Observational (n=18)
Does individualized medical therapy prevent recurrent syncope in pediatric patients with cardioinhibitory syncope?
Pharmacological therapy appears safe and effective for managing recurrent syncope with asystole in young patients, potentially avoiding the need for pacemaker implantation.
Deal et al. (1997) conducted an observational in Recurrent syncope with asystole (n=18). Medical management was evaluated on Freedom from recurrent syncope. Individualized medical therapy for pediatric patients with recurrent syncope and asystole during tilt testing prevented recurrent syncope in 78% of patients over a median 31-month follow-up.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: